Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy (Q38317118)

2 September 2017

Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy (English)

1 reference

2 September 2017

0 references

1 reference

P Johansen

1

1 reference

2 September 2017

G Senti

2

1 reference

2 September 2017

J M Martinez Gomez

3

1 reference

2 September 2017

T Storni

4

1 reference

2 September 2017

B R von Beust

5

1 reference

2 September 2017

B Wüthrich

6

1 reference

2 September 2017

A Bot

7

1 reference

2 September 2017

T M Kündig

8

1 reference

2 September 2017

1 December 2005

1 reference

Clinical & Experimental Allergy

2 September 2017

1 reference

2 September 2017

35

1 reference

2 September 2017

12

1 reference

2 September 2017

1591-1598

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

2 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Induction of direct antimicrobial activity through mammalian toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

TLRs: Professor Mechnikov, sit on your hat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Intralymphatic immunization enhances DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Direct intralymphatic injection of peptide vaccines enhances immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

From allergen structure to new forms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Discovery of immunopotentiatory drugs: current and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

CpG DNA and immunotherapy of allergic airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Mitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

Memory B-cell persistence is independent of persisting immunizing antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

B-cell memory is short-lived in the absence of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02384.X

10.1111/J.1365-2222.2005.02384.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference